Challenge: Open FDA 483 Observations With No Clear Root Cause
A commercial biotech company with approximately $12B in revenue needed to respond to FDA 483 warning letters and resolve the associated CAPAs. A previous analysis had already been performed, but it never successfully determined the root cause of the observations, leaving the company exposed to repeat findings.
The situation demanded a fast but thorough remediation solution, and the company lacked internal resources with the knowledge and experience to assess and remediate the current observations on its own. Without a credible, root-cause-driven response, the organization risked an inadequate reply to the FDA and continued data integrity vulnerabilities.
- Commercial biotech company with approximately $12B in revenue
- Needed to address FDA 483 warning letters and CAPAs
- Previous analysis was done, but the root cause was not successfully determined
- Required a fast but thorough remediation solution
- Lacked internal resources with the knowledge and experience to assess and remediate the current observations
Approach: Targeted Assessment of CSV and Data Integrity
USDM started with a high-level audit to guide assessors to the critical areas for investigation, then went deep on the systems and practices most likely to be driving the findings.
Pinpoint the Real Issues
- Conducted a high-level audit to guide assessors to the critical areas for investigation
- Conducted an assessment of the company's computer system validation (CSV) processes
- Conducted an assessment of data integrity processes and practices, grounded in 21 CFR Part 11 expectations
Build Lasting Capability
Beyond the immediate response, USDM equipped the customer to sustain compliance after the engagement ended.
- Developed tools for the customer to evaluate their CSV and data integrity capabilities in the future
- Developed process maps to identify potential and unforeseen data integrity vulnerabilities before they become findings
- Deployed reusable tools using criteria provided by the customer that were easy to understand and followed a transparent data model
Results: Trustworthy, Rapid Remediation That Sticks
The engagement delivered a response the FDA could trust, fixed the underlying causes the prior analysis had missed, and left the company with a stronger program for the long term.
- Trustworthy, rapid delivery of responses to the FDA findings
- A remediation solution that addresses the root causes of the violations
- A more robust data integrity program implemented, backed by reusable self-assessment tools and process maps
By pairing a root-cause-driven 483 response with durable tooling, USDM helped the company move from reactive firefighting toward continuous compliance. For organizations that want to stay audit-ready between inspections, the same discipline extends through USDM Cloud Assurance.